A

Ascendis Pharma A/S
D

ASND

129.840
USD
7.20
(5.87%)
Market Closed
Volume
10,861
EPS
-8
Div Yield
-
P/E
-17
Market Cap
7,759,292,154
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.120
    (0.84%)
    14.400 USD
    AMP
    AMP
    0.99
    (0.18%)
    562.53 USD
    B
    BFS
    0.020
    (0.05%)
    39.450 USD
    C
    CF
    1.320
    (1.54%)
    87.050 USD
    ETN
    ETN
    -2.94
    (-0.81%)
    359.00 USD
    L
    LSXMA
    0
    (0%)
    0.000000 USD
    O
    OCFC
    0.000
    (0.00%)
    20.470 USD
    T
    TKR
    0.620
    (0.83%)
    75.590 USD
    More
News

Title: Ascendis Pharma A/S

Sector: Healthcare
Industry: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.